Investor Relations > Press Release

Press Release

Printer Friendly Version View printer-friendly version
<< Back
Hi-Tech Pharmacal to Release First Quarter Fiscal 2004 Results on September 15, 2003 and Schedules a Conference Call for September 16, 2003

AMITYVILLE, N.Y., Sep 12, 2003 (BUSINESS WIRE) -- Hi-Tech Pharmacal Co., Inc. (NASDAQ:HITK) will release its first quarter fiscal 2004 results on Monday, September 15, 2003. The Company will hold a conference call to discuss its first quarter results on Tuesday, September 16, 2003 at 1 p.m. Eastern Time.

To access the conference call, dial toll free 800-901-5213, or 617-786-2962 for international callers, five minutes before the conference. The passcode of the conference call is 47673672.

A replay of the conference call will be available one hour after the conference call for one week by calling toll free 888-286-8010, or 617-801-6888 for international callers. The passcode for the replay TBD.

About Hi-Tech

Hi-Tech is a specialty pharmaceutical company developing, manufacturing and marketing branded and generic products for the general healthcare industry. The Company specializes in difficult to manufacture liquid and semi-solid dosage forms and produces a range of sterile ophthalmic, otic and inhalation products. The Company's Health Care Products Division is a leading developer and marketer of branded prescription and OTC products for the diabetes marketplace.

Statements concerning future results in this release may constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectation and the current economic environment. These statements involve a number risks and uncertainties, including but not limited to the impact of competitive products and pricing, product demand and market acceptance, new product development, reliance on key strategic alliances, availability of raw materials, the regulatory environment, fluctuations in operating results and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission. Actual results could differ materially from those expressed or implied in the forward-looking statements and these statements are not guarantees of the future performance.

Hi-Tech Pharmacal Co., Inc.
David Seltzer or Tanya Akimova
631-789-8228
Fax 631-789-8824

© Hi-Tech Pharmacal Co. Inc (a NASDAQ company)